|
Volumn 105, Issue 4, 1992, Pages 787-791
|
Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist
a a a a a a a a a a a a |
Author keywords
aquaresis; nonpeptide antagonist; OPC 31260; V2 receptor; vasopressin
|
Indexed keywords
ARGIPRESSIN;
DIURETIC AGENT;
FUROSEMIDE;
HYDROCHLOROTHIAZIDE;
MOZAVAPTAN;
N [4 [(5 DIMETHYLAMINO 2,3,4,5 TETRAHYDRO 1H BENZAZEPIN 1 YL)CARBONYL]PHENYL] 2 METHYLBENZAMIDE;
RECEPTOR BLOCKING AGENT;
SPIRONOLACTONE;
UNCLASSIFIED DRUG;
VASOPRESSIN RECEPTOR;
VASOPRESSIN RECEPTOR ANTAGONIST;
ANIMAL TISSUE;
ARTICLE;
DIURESIS;
DRUG ANTAGONISM;
DRUG RECEPTOR BINDING;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY;
LIVER;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
URINE OSMOLALITY;
ADMINISTRATION, ORAL;
ANIMAL;
ARGIPRESSIN;
BENZAZEPINES;
BINDING, COMPETITIVE;
CELL MEMBRANE;
DIURESIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
IN VITRO;
KIDNEY;
LIVER;
MALE;
NATRIURESIS;
RATS;
RECEPTORS, ANGIOTENSIN;
RECEPTORS, VASOPRESSIN;
|
EID: 0026533435
PISSN: 00071188
EISSN: 14765381
Source Type: Journal
DOI: 10.1111/j.1476-5381.1992.tb09058.x Document Type: Article |
Times cited : (353)
|
References (20)
|